Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | RAB9A | P51151 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | NOS3 | P29474 | 2/20 | 0.43 |
| ▸ | NOS1 | P29475 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | STAT1 | P42224 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | STS | P08842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4102019 | 0.92 | HSD17B1 (0.61) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL6956930 | 0.92 | MAPT (0.55) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL7929382 | 0.90 | MAOB (0.47) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL5320294 | 0.90 | KMT2A (0.53) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL9367770 | 0.87 | ALDH1A1 (0.53) | MAPK1MAPTRAB9ALMNAKMT2A | |
| SCHEMBL31256698 | 0.84 | MAPK1 (0.47) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL9228034 | 0.82 | MAPT (0.42) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL3198744 | 0.82 | MAPT (0.54) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL22539176 | 0.82 | MAPK1 (0.45) | MAPK1MAPTRAB9AHPGDLMNA | |
| SCHEMBL50646 | 0.79 | MAPT (0.68) | MAPK1MAPTRAB9AHPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2186799-B1 | AROMATIC SULFONIUM SALT COMPOUND | ADEKA CORP (JP) | 2015-07-08 | — | — | EP | disclosed |
| CN-101778818-B | Aromatic sulfonium salt compound | ADEKA CORP | 2014-01-08 | — | — | CN | disclosed |
| EP-2308865-B1 | Novel aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping, and method of optically forming three-dimensional shape | ADEKA CORP (JP) | 2013-08-07 | — | — | EP | disclosed |
| EP-1557413-B1 | NOVEL AROMATIC SULFONIUM SALT COMPOUND, PHOTO-ACID GENERATOR COMPRISING THE SAME AND PHOTOPOLYMERIZABLE COMPOSITION CONTAINING THE SAME, RESIN COMPOSITION FOR OPTICAL THREE-DIMENSIONAL SHAPING, AND METHOD OF OPTICALLY FORMING THREE-DIMENSIONAL SHAPE | ADEKA CORP (JP) | 2012-08-01 | — | — | EP | disclosed |
| US-8227624-B2 | Aromatic sulfonium salt compound | ADEKA CORPORATION (JP) | 2012-07-24 | — | — | US | disclosed |
| US-20110152540-A1 | AROMATIC SULFONIUM SALT COMPOUND | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| EP-2308865-A1 | Novel aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping, and method of optically forming three-dimensional shape | Adeka Corporation (JP) | 2011-04-13 | — | — | EP | disclosed |
| CN-101778818-A | Aromatic sulfonium salt compound | ADEKA COR | 2010-07-14 | — | — | CN | disclosed |
| EP-2186799-A1 | AROMATIC SULFONIUM SALT COMPOUND | Adeka Corporation (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-7611817-B2 | Capable of providing stereolithographic resin compositions which do not suffer from hindrance to curing by oxygen, can easily give shaped articles having desired sizes by virtue of high accuracy thereof in curing, can attain satisfactory curing depth owing to high sensitivity thereof for radiant energy | ADEKA CORPORATION (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20060055088-A1 | Novel aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping and method of optically forming tree-dimensional shape | ASAHI DENKA CO. LTD. (JP) | 2006-03-16 | — | — | US | disclosed |
| EP-1557413-A1 | NOVEL AROMATIC SULFONIUM SALT COMPOUND, PHOTO-ACID GENERATOR COMPRISING THE SAME AND PHOTOPOLYMERIZABLE COMPOSITION CONTAINING THE SAME, RESIN COMPOSITION FOR OPTICAL THREE-DIMENSIONAL SHAPING, AND METHOD OF OPTICALLY FORMING THREE-DIMENSIONAL SHAPE | Asahi Denka Co., Ltd. (JP) | 2005-07-27 | — | — | EP | disclosed |
| US-4036818-A | Method of preparing polymers of polyphenylene type | KORSHAK VASILY VLADIMIROVICH | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060055088-A1 | Novel aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping and method of optically forming tree-dimensional shape | ARSA, NOX5, ATIC | MAPK1 629/4885MAPT 1930/4885RAB9A 2360/4885 |
| US-20110152540-A1 | AROMATIC SULFONIUM SALT COMPOUND | SLC43A1, SLC7A5, SPIN2B | MAPK1 2278/4885MAPT 2042/4885RAB9A 1716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.